Lotus Pharm vs Welgene Biotech: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Welgene Biotech (6661) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Welgene Biotech

0%+226%-31%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYWelgene BiotechYoY
Oct 2026NT$2.13 billion-22.5%NT$33.9 million+22.2%
Sep 2026NT$2.77 billion+128.0%NT$35.5 million+19.6%
Aug 2026NT$2.11 billion+81.7%NT$32.3 million-31.2%
Jul 2026NT$2.49 billion+3.9%NT$33.2 million-0.9%
Jun 2026NT$3.4 billion+225.5%NT$33.3 million+0.1%
May 2026NT$2.32 billion+105.8%NT$43.1 million+33.4%
Apr 2026NT$3.09 billion+19.9%NT$30.8 million+25.5%
Mar 2026NT$4.35 billion+173.6%NT$28.8 million+0.9%
Feb 2026NT$2.24 billion+131.5%NT$26 million-2.9%
Jan 2026NT$2.05 billion-5.5%NT$29 million+28.2%
Dec 2025NT$2.44 billion+66.9%NT$36 million+8.2%
Nov 2025NT$1.06 billion-0.2%NT$34.1 million+15.6%
Oct 2025NT$2.75 billion+46.0%NT$27.8 million+11.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16